Research Topic:
The assessment of elevating immunity of cancer patients with Tien Hsien Liquid.
(Clinical Trial Research on the Influence of Tien Hsien Liquid on the Immunocompetent Cell of the Thymus Dependent Lymphocyte)
Research Conclusion:
1. The average efficacy of Tien Hsien Liquid on various randomly selected
tumor patients can reach as high as 45.7%.
2. The efficacy of Tien Hsien Liquid for breast tumor patients may reach 83.3%.
3. The Tien Hsien may effectively increase the activation of the
Immunocompetent Cell of the Thymus Dependent Lymphocyte.
Project Manager:
Yeh Chi-Yuan Master of Medical Science, Taipei Medical University
Director of Tumor Center, Tung’s Taichung
MetroHarbor Hospital